tiprankstipranks
Unity Biotechnology Inc (UBX)
NASDAQ:UBX

Unity Biotechnology (UBX) Financial Statements

675 Followers

Unity Biotechnology Financial Overview

Unity Biotechnology's market cap is currently ―. The company's EPS TTM is $-3.654; its P/E ratio is -0.45; Unity Biotechnology is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 976.00K$ 965.00K$ 963.00K$ -1.05M$ 0.00
Gross Profit$ 976.00K$ 965.00K$ 963.00K$ -1.05M-
EBIT$ -14.82M$ -11.23M$ -9.86M$ -13.98M$ -12.84M
EBITDA$ -14.83M$ -10.97M$ -9.65M$ -13.67M$ -12.31M
Net Income Common Stockholders$ -15.29M$ -12.21M$ -10.87M$ -14.17M$ -13.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 45.94M$ 69.09M$ 83.39M$ 94.80M$ 98.94M
Total Assets$ 69.27M$ 101.01M$ 114.25M$ 124.35M$ 136.39M
Total Debt$ 24.43M$ 43.08M$ 46.83M$ 47.36M$ 47.83M
Net Debt$ -21.51M$ -26.01M$ -36.56M$ -47.44M$ -51.11M
Total Liabilities$ 33.06M$ 51.60M$ 55.63M$ 57.50M$ 57.83M
Stockholders Equity$ 36.21M$ 49.43M$ 58.63M$ 66.85M$ 78.56M
Cash Flow-
Free Cash Flow$ -7.12M$ -11.08M$ -11.32M$ -10.30M$ -10.90M
Operating Cash Flow$ -7.11M$ -11.08M$ -11.32M$ -10.37M$ -10.86M
Investing Cash Flow$ 14.25M$ 9.85M$ 21.28M$ -191.00K$ -36.23M
Financing Cash Flow$ -18.38M$ -2.63M$ 274.00K$ 167.00K$ 50.22M
Currency in USD

Unity Biotechnology Earnings and Revenue History

Unity Biotechnology Debt to Assets

Unity Biotechnology Cash Flow

Unity Biotechnology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis